Quick Answer
Lipocine Inc. reported Total Revenue of $1.98 million for fiscal year 2025.
Lipocine Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $1.98M | -82.3% |
| 2024 | $11.20M | +492.8% |
| 2023 | -$2.85M | -670.2% |
| 2022 | $500.0K | -96.9% |
| 2021 | $16.14M | — |
| 2020 | $0.00 | -100.0% |
| 2019 | $165.0K | -61.5% |
| 2018 | $428.0K | — |
| 2017 | $0.00 | — |
| 2016 | $0.00 | — |
| 2013 | $0.00 | -100.0% |
| 2012 | $7.71M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $114.6K | — | -81.6% |
| June 30, 2025 | $622.8K | +595.4% | +563.6% |
| March 31, 2025 | $93.9K | -98.8% | +4.8% |
| June 30, 2024 | $89.6K | — | -98.8% |
| March 31, 2024 | $7.62M | +13751.9% | +344.0% |
| September 30, 2023 | -$3.12M | — | -5777.4% |
| March 31, 2023 | $55.0K | — | -89.0% |
| June 30, 2022 | $500.0K | — | +809.2% |
- Lipocine Inc. showed a decrease of -82.3% in Total Revenue compared to the prior fiscal year.
- Over the 2012–2025 period, Lipocine Inc.’s total revenue has declined by 74.4% (from $7.71 million to $1.98 million).
- The most recent figure is from Lipocine Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 10, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: